Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Elza C. de Bruin, Nicholas McGranahan, Richard Mitter, et al.
Science (2014) Vol. 346, Iss. 6206, pp. 251-256
Open Access | Times Cited: 1051

Showing 1-25 of 1051 citing articles:

Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo‐Jack, Alice T. Shaw
Nature Reviews Clinical Oncology (2017) Vol. 15, Iss. 2, pp. 81-94
Closed Access | Times Cited: 2920
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan, Andrew J.S. Furness, Rachel Rosenthal, et al.
Science (2016) Vol. 351, Iss. 6280, pp. 1463-1469
Open Access | Times Cited: 2756
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan, Charles Swanton
Cell (2017) Vol. 168, Iss. 4, pp. 613-628
Open Access | Times Cited: 2354
The PI3K Pathway in Human Disease
David A. Fruman, Honyin Chiu, Benjamin D. Hopkins, et al.
Cell (2017) Vol. 170, Iss. 4, pp. 605-635
Open Access | Times Cited: 2171
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan, Charles Massie, Javier García-Corbacho, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 4, pp. 223-238
Open Access | Times Cited: 2160
Tracking the Evolution of Non–Small-Cell Lung Cancer
Mariam Jamal‐Hanjani, Gareth A. Wilson, Nicholas McGranahan, et al.
New England Journal of Medicine (2017) Vol. 376, Iss. 22, pp. 2109-2121
Open Access | Times Cited: 2125
Comprehensive genomic profiles of small cell lung cancer
Julie George, Jing Lim, Se Jin Jang, et al.
Nature (2015) Vol. 524, Iss. 7563, pp. 47-53
Open Access | Times Cited: 1991
The evolutionary significance of polyploidy
Yves Van de Peer, Eshchar Mizrachi, Kathleen Marchal
Nature Reviews Genetics (2017) Vol. 18, Iss. 7, pp. 411-424
Closed Access | Times Cited: 1439
Artificial intelligence in cancer imaging: Clinical challenges and applications
Wenya Linda Bi, Ahmed Hosny, Matthew B. Schabath, et al.
CA A Cancer Journal for Clinicians (2019) Vol. 69, Iss. 2, pp. 127-157
Open Access | Times Cited: 1416
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
Rachel Rosenthal, Nicholas McGranahan, Javier Herrero, et al.
Genome biology (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 1087
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Joshua D. Campbell, Anton Alexandrov, Jaegil Kim, et al.
Nature Genetics (2016) Vol. 48, Iss. 6, pp. 607-616
Open Access | Times Cited: 1064
Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
Nicholas McGranahan, Charles Swanton
Cancer Cell (2015) Vol. 27, Iss. 1, pp. 15-26
Open Access | Times Cited: 1007
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata, Matthew J. Niederst, Hannah L. Archibald, et al.
Nature Medicine (2016) Vol. 22, Iss. 3, pp. 262-269
Open Access | Times Cited: 881
Non-small-cell lung cancer
Cesare Gridelli, Antônio Rossi, David P. Carbone, et al.
Nature Reviews Disease Primers (2015) Vol. 1, Iss. 1
Closed Access | Times Cited: 846
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
Ferdinandos Skoulidis, Lauren A. Byers, Lixia Diao, et al.
Cancer Discovery (2015) Vol. 5, Iss. 8, pp. 860-877
Open Access | Times Cited: 783
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Ferdinandos Skoulidis, John V. Heymach
Nature reviews. Cancer (2019) Vol. 19, Iss. 9, pp. 495-509
Open Access | Times Cited: 772
Mutational landscape and clonal architecture in grade II and III gliomas
Hiromichi Suzuki, Kosuke Aoki, Kenichi Chiba, et al.
Nature Genetics (2015) Vol. 47, Iss. 5, pp. 458-468
Closed Access | Times Cited: 771
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Lucy Yates, Moritz Gerstung, Stian Knappskog, et al.
Nature Medicine (2015) Vol. 21, Iss. 7, pp. 751-759
Open Access | Times Cited: 766
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
Matthew T. Chang, Saurabh Asthana, Sizhi Paul Gao, et al.
Nature Biotechnology (2015) Vol. 34, Iss. 2, pp. 155-163
Open Access | Times Cited: 742
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Dany Nassar, Cédric Blanpain
Annual Review of Pathology Mechanisms of Disease (2016) Vol. 11, Iss. 1, pp. 47-76
Closed Access | Times Cited: 725
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig, Johann von Felden, Teresa García‐Lezana, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 3, pp. 139-152
Closed Access | Times Cited: 681
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar, Ilsa M. Coleman, Colm Morrissey, et al.
Nature Medicine (2016) Vol. 22, Iss. 4, pp. 369-378
Open Access | Times Cited: 679
High-Spatial-Resolution Multi-Omics Sequencing via Deterministic Barcoding in Tissue
Yang Liu, Mingyu Yang, Yanxiang Deng, et al.
Cell (2020) Vol. 183, Iss. 6, pp. 1665-1681.e18
Open Access | Times Cited: 660
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan, Francesco Favero, Elza C. de Bruin, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 283
Open Access | Times Cited: 649
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
Richard B. Lanman, Stefanie Mortimer, Oliver A. Zill, et al.
PLoS ONE (2015) Vol. 10, Iss. 10, pp. e0140712-e0140712
Open Access | Times Cited: 643
Page 1 - Next Page

Scroll to top